Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-13

Clinical Trial Update: Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study) [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing gemigliptin to sitagliptin or glimepiride, each added to metformin, assessing glucose variability in type 2 diabetes. The study is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gemigliptin (gemigliptin)
  • Glimepiride (glimepiride)
  • Sitagliptin (sitagliptin)
  • metformin (metformin)

Snippet

Sponsor: LG Life Sciences | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED